Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases (prnewswire.com) List PREV Sonoma Biotherapeutics Raises $265 Million in an Oversubscribed Series B Financing to Translate the NEXT ReCode Scores $80 Million to Advance mRNA-Based Cystic Fibrosis, PCD Programs
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases (prnewswire.com) List PREV Sonoma Biotherapeutics Raises $265 Million in an Oversubscribed Series B Financing to Translate the NEXT ReCode Scores $80 Million to Advance mRNA-Based Cystic Fibrosis, PCD Programs
PREV Sonoma Biotherapeutics Raises $265 Million in an Oversubscribed Series B Financing to Translate the NEXT ReCode Scores $80 Million to Advance mRNA-Based Cystic Fibrosis, PCD Programs
